Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Refuse Disposal
Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores-Reply.
L-Selectin
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines.
X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines. Cancer Res. 1988 Sep 15; 48(18):5133-5.
View in:
PubMed
subject areas
Adenocarcinoma
Carcinoma, Squamous Cell
Cell Line
Cisplatin
Humans
Phenotype
Sarcoma
X-Rays
authors with profiles
Ralph Weichselbaum